These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3334007)

  • 21. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 22. [Live vaccines for the prevention of intestinal infections].
    Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
    Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenicity and antigenic relatedness of the outer membrane proteins of Shigella species.
    Roy S; Das AB; Biswas T
    Microbios; 1994; 79(318):55-64. PubMed ID: 7521507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of the O antigen of Shigella sonnei by a competitive immunoenzyme method].
    Voronov AV; Sazykin AIu; Vengerov IuIu; Serebriakov MIu; Malov VA
    Antibiot Khimioter; 1988 Jan; 33(1):43-6. PubMed ID: 2454084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of specific antibodies in dysentery].
    Bunin KV; Belaia OF
    Sov Med; 1984; (10):19-22. PubMed ID: 6393359
    [No Abstract]   [Full Text] [Related]  

  • 28. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Shigella interaction with immune enterocytes].
    Polotskiĭ IuE; Seliverstova VG; Rukhamina ML; Krasnoproshina LI
    Arkh Patol; 1980; 42(12):39-46. PubMed ID: 7011272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective properties of peptidoglycan associated protein of Shigella flexneri.
    Mulczyk M; Adamus G; Witkowska D
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):631-5. PubMed ID: 6398687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of tumor necrosis factor and nitric oxide by Shigella strains isolated from patients with or without neurologic manifestations.
    Mor M; Yuhas Y; Kaminsky E; Dinari G; Ashkenazi S
    Isr J Med Sci; 1996 Dec; 32(12):1271-5. PubMed ID: 9007170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obtaining dysentery and salmonellosis diagnostica for the coagglutination reaction in lyophilized form and the elaboration of a rapid system].
    Belaia IuA; Belaia OF
    Lab Delo; 1982; (8):486-8. PubMed ID: 6182376
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB.
    Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A
    PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-diagnostic significance of specific antigenemia in acute dysentery].
    Abdurakhmanova EG; Timina VP; Shabalina SV
    Sov Med; 1984; (5):114-6. PubMed ID: 6205453
    [No Abstract]   [Full Text] [Related]  

  • 39. [Local Immune response in rabbits following enteral immunization with live attenuated bacterial Enterobacteriaceae vaccines].
    Dentschev W; Marinova S; Sumerska T; Nenkov P; Koitschev T; Trifonowa A
    Arch Exp Veterinarmed; 1980; 34(1):9-13. PubMed ID: 6998404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of outer membrane proteins of virulent phase I Shigella sonnei strains and their avirulent phase I derivatives.
    Adamus G; Mulczyk M; Witkowska D
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):513-6. PubMed ID: 3296995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.